From: Characterizing patients with rare mucormycosis infections using real-world data
Overall HM cohort N = 962,428 | HM and IM cohort N = 1133 | |||
---|---|---|---|---|
n | % | n | % | |
Any antifungal treatment | 119,414 | 12.41 | 382 | 33.72 |
Fluconazole | 109,372 | 11.36 | 275 | 24.27 |
Voriconazole | 9657 | 1.00 | 137 | 12.09 |
Micafungin | 9443 | 0.98 | 72 | 6.35 |
Posaconazole | 5080 | 0.53 | 185 | 16.33 |
Any amphotericin B | 3521 | 0.37 | 177 | 15.62 |
Itraconazole | 2685 | 0.28 | 24 | 2.12 |
Caspofungin | 2635 | 0.27 | 56 | 4.94 |
Anidulafungin | 1972 | 0.20 | 16 | 1.41 |
Isavuconazole | 825 | 0.09 | 59 | 5.21 |